Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II Study of Atezolizumab w/ Cobimetinib vs Atezolizumab Monotherapy in Unresectable Cholangioca

Protocol: OSU-18001

Full Title

A Randomized Phase II Study of Atezolizumab in Combination with Cobimetinib versus Atezolizumab Monotherapy in Participants with Unresectable Cholangiocarcinoma

Gastrointestinal Cancers Gallbladder Cancer